Core 2: Biospecimen, Metabolomics, and Pathology Core
核心 2:生物样本、代谢组学和病理学核心
基本信息
- 批准号:10711640
- 负责人:
- 金额:$ 13.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-23 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AwardBiostatistics CoreBloodCancer CenterCancer ModelCancer PatientCatalogsCellsCharacteristicsClinicalClinical DataCollaborationsCollectionCommunitiesConsentCorrelative StudyCredentialingDataDatabasesDevelopmentDiagnosisDiseaseEligibility DeterminationEndometrial CarcinomaEnsureEquipment and supply inventoriesEquityEvaluationExperimental DesignsFreezingFutureGoalsGrantInfrastructureInstitutionInstitutional Review BoardsIsotopesLeadershipLinkLiquid substanceManuscriptsMetabolicMethodsNew MexicoNewly DiagnosedNucleic AcidsOklahomaOrganoidsOutcomePathologyPatientsPeer ReviewPlasmaPreparationProcessPrognostic FactorProtocols documentationPublicationsQualifyingRecurrenceResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesRouteSamplingSerumServicesSpecimenStandardizationStructureTimeTissuesTranslational ResearchUniversitiesValidationWashingtonWorkanticancer researchbiobankcareerclinical databasedata interoperabilitydata sharingexperiencegenome sequencingmetabolomicsmodel developmentoperationpatient derived xenograft modelpreservationpreventprogramsprospectivesample collectionsecondary analysissuccesstoolwhole genome
项目摘要
PROJECT SUMMARY/ABSTRACT
The goal of the Biospecimen, Metabolomics, and Pathology Core (BMP Core) is to create a federated, multi-
institutional resource to provide high-quality, clinically annotated biospecimens, metabolomic analyses, and
expert pathology review to all research projects in this SPORE application as well as future SPORE-sponsored
DRP and CEP projects, while serving as an unparalleled biospecimen resource to the broader endometrial
cancer research community. The Core will provide specific tissue and biosample-related services for each
SPORE project. In addition, the BMP Core will prospectively build a biospecimen resource bank at WUSTL,
OUHSC, and UNM by identifying cases of new and recurrent endometrial cancer at the participating institutions
and facilitating the consent and procurement process. Tissue and fluid biospecimens from these patients will
be collected, processed, and stored by leveraging the extensive infrastructure of existing biorepositories at the
participating institutions. Clinical data will be collected prospectively by integrating with and extending existing
clinical databases. Interactions with the Biostatistics Core will ensure interoperability of data tables maintained
at each institution. The BMP Core will provide access to the world-class Center for Metabolomics and Isotope
Tracing at WUSTL. Validated methods for sample processing and preservation, focused on optimizing
metabolic analyses, will be provided to increase the scientific utility of all biospecimens collected. A
transparent and equitable mechanism to publicize existing biospecimen resources and evaluate any request
for their use will be implemented. As such, the BMP Core will supplement existing cancer center resources
with focused expertise and effort to comprehensively collect, annotate, quality review, and distribute
biospecimens specifically for translational endometrial cancer research.
项目摘要/摘要
生物测量,代谢组学和病理学核心(BMP核心)的目标是创建一个联合的,多的
提供高质量的,临床注释的生物测量,代谢组分分析和
专家病理学评论本孢子应用中的所有研究项目以及未来的孢子赞助
DRP和CEP项目,同时充当更广泛子宫内膜的无与伦比的生物测量资源
癌症研究界。核心将为每种提供特定的组织和生物样品相关服务
孢子项目。此外,BMP Core将前瞻性地在Wustl建立生物循环资源银行
OUHSC,以及通过在参与机构中识别新的和经常性子宫内膜癌病例
并促进同意和采购过程。这些患者的组织和液体生物测量将
通过利用现有生物库的广泛基础设施来收集,处理和存储
参与机构。临床数据将通过与现有的集成并扩展到前瞻性收集
临床数据库。与生物统计学核心的相互作用将确保维护数据表的互操作性
在每个机构。 BMP核心将提供进入世界一流代谢组学和同位素中心的访问权限
跟踪Wustl。经过验证的样品处理和保存方法,专注于优化
将提供代谢分析,以增加收集的所有生物测量的科学效用。一个
透明且公平的机制,以宣传现有的生物循环资源并评估任何请求
为了使用它们。因此,BMP核心将补充现有的癌症中心资源
凭借重点的专业知识和努力,以全面收集,注释,质量审查和分发
专门用于转化子宫内膜癌研究的生物测量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ian S. Hagemann其他文献
Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids
Neratinib 与曲妥珠单抗抗体药物偶联物或长春瑞滨协同治疗 HER2 突变乳腺癌患者的异种移植物和类器官
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Shunqiang Li;Tina M Primeau;Maureen K. Highkin;S. L. Pratt;Ashley R. Tipton;Nagalaxmi Vemalapally;J. Monsey;Yu Tao;Jingqin Luo;Ian S. Hagemann;Chieh;L. Eli;Cynthia X Ma;R. Bose - 通讯作者:
R. Bose
Pathologic findings in fallopian tubes of women with chronic pelvic pain after Essure placement
- DOI:
10.1016/j.contraception.2020.04.010 - 发表时间:
2020-08-01 - 期刊:
- 影响因子:
- 作者:
Alexandra Rubin;Jie-Fu Chen;Ashley Veade;Ian S. Hagemann - 通讯作者:
Ian S. Hagemann
Controversies in Gynecologic Cancer Staging: An AJCC Cancer Staging Manual, Eighth Edition Perspective
妇科癌症分期的争议:AJCC 癌症分期手册,第八版观点
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Ian S. Hagemann;Lisa L. Cole;Jonathan A. Cosin;Donna M. Gress;David G. Mutch;A. Olawaiye - 通讯作者:
A. Olawaiye
E2f8 Is a Nonreceptor Activator of Heterotrimeric G Proteins Recommended Citation Journal of Molecular Signaling Open Access E2f8 Is a Nonreceptor Activator of Heterotrimeric G Proteins
E2f8 是异三聚 G 蛋白的非受体激活剂 推荐引文 分子信号转导开放获取杂志 E2f8 是异三聚 G 蛋白的非受体激活剂
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Ian S. Hagemann;Kirk D Narzinski;Thomas J. Baranski;Kirk;J. Baranski - 通讯作者:
J. Baranski
Ian S. Hagemann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Administrative, data management and biostatistics core
行政、数据管理和生物统计核心
- 批准号:
10642593 - 财政年份:2023
- 资助金额:
$ 13.04万 - 项目类别:
Kansas Center for Metabolism and Obesity REsearch (KC-MORE) - Cells, Tissues, Bioanalysis and Biostatistics Core
堪萨斯代谢和肥胖研究中心 (KC-MORE) - 细胞、组织、生物分析和生物统计学核心
- 批准号:
10598036 - 财政年份:2022
- 资助金额:
$ 13.04万 - 项目类别:
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
一氧化氮免疫依赖性抗 PD-1 疗法的耐药机制
- 批准号:
10214904 - 财政年份:2021
- 资助金额:
$ 13.04万 - 项目类别:
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
一氧化氮免疫依赖性抗 PD-1 疗法的耐药机制
- 批准号:
10475071 - 财政年份:2021
- 资助金额:
$ 13.04万 - 项目类别: